Royalty Pharma Increases Bid for Elan
Royalty says it will pay $12.50 in cash for each share of Elan.
-
Business
Featured Story
-
Marketing & Advertising
Featured Story
Glaxo Hit the Most By Drug Price Control Order
HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
-
R&D
Featured Story
FDA, Peregrine Agree on Phase III Bavituximab Study
Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...
-
Therapeutics
Featured Story
Pfizer Halts Study of Non-Hodgkin's Lymphoma Drug
An interim analysis showed the drug wasn't helping patients live longer
-
Pharmalot
Featured Story
Pharmalot... Pharmalittle... Good Morning
Rise and shine, everyone. Another busy day is on the way, and we are no exception. We have an interesting meeting planned and, of course, various...
- Resources
- Directories
- Manny Awards
- Events
- Jobs